Borregaard ASA
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The company develops, produces, and sells biopolymers and biovanillin for agrochemicals, batteries, industrial binders, and construct… Read more
Borregaard ASA (BRRDF) - Net Assets
Latest net assets as of September 2025: $594.77 Million USD
Based on the latest financial reports, Borregaard ASA (BRRDF) has net assets worth $594.77 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($992.39 Million) and total liabilities ($397.62 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $594.77 Million |
| % of Total Assets | 59.93% |
| Annual Growth Rate | 9.22% |
| 5-Year Change | 34.73% |
| 10-Year Change | 146.97% |
| Growth Volatility | 16.09 |
Borregaard ASA - Net Assets Trend (2009–2024)
This chart illustrates how Borregaard ASA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Borregaard ASA (2009–2024)
The table below shows the annual net assets of Borregaard ASA from 2009 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $5.09 Billion | +4.00% |
| 2023-12-31 | $4.89 Billion | +10.10% |
| 2022-12-31 | $4.45 Billion | +3.23% |
| 2021-12-31 | $4.31 Billion | +13.98% |
| 2020-12-31 | $3.78 Billion | +9.06% |
| 2019-12-31 | $3.46 Billion | +4.31% |
| 2018-12-31 | $3.32 Billion | +10.85% |
| 2017-12-31 | $3.00 Billion | +10.43% |
| 2016-12-31 | $2.71 Billion | +31.64% |
| 2015-12-31 | $2.06 Billion | +5.75% |
| 2014-12-31 | $1.95 Billion | +5.01% |
| 2013-12-31 | $1.86 Billion | +6.85% |
| 2012-12-31 | $1.74 Billion | +54.67% |
| 2011-12-31 | $1.12 Billion | +10.75% |
| 2010-12-31 | $1.01 Billion | -25.17% |
| 2009-12-31 | $1.35 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Borregaard ASA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 293400000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $2.93 Billion | 58.20% |
| Common Stock | $100.00 Million | 1.98% |
| Other Comprehensive Income | $661.00 Million | 13.11% |
| Other Components | $1.35 Billion | 26.70% |
| Total Equity | $5.04 Billion | 100.00% |
Borregaard ASA Competitors by Market Cap
The table below lists competitors of Borregaard ASA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SHG:603392
|
$1.39 Billion |
|
Betsson AB (publ)
PINK:BTSNY
|
$1.39 Billion |
|
Jereissati Participações S.A.
SA:IGTI11
|
$1.39 Billion |
|
Ryman Healthcare Limited
PINK:RHCGF
|
$1.39 Billion |
|
Hakuhodo DY Holdings Inc
OTCGREY:HKUOF
|
$1.39 Billion |
|
Jonjee Hi-tech Industrial and Commercial Holding Co Ltd
SHG:600872
|
$1.39 Billion |
|
Betta Pharmaceuticals Co Ltd
SHE:300558
|
$1.39 Billion |
|
Innodata Inc
NASDAQ:INOD
|
$1.39 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Borregaard ASA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,855,000,000 to 5,041,000,000, a change of 186,000,000 (3.8%).
- Net income of 823,000,000 contributed positively to equity growth.
- Dividend payments of 374,000,000 reduced retained earnings.
- Share repurchases of 98,000,000 reduced equity.
- New share issuances of 52,000,000 increased equity.
- Other comprehensive income increased equity by 673,468,224.
- Other factors decreased equity by 890,468,224.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $823.00 Million | +16.33% |
| Dividends Paid | $374.00 Million | -7.42% |
| Share Repurchases | $98.00 Million | -1.94% |
| Share Issuances | $52.00 Million | +1.03% |
| Other Comprehensive Income | $673.47 Million | +13.36% |
| Other Changes | $-890.47 Million | -17.66% |
| Total Change | $- | 3.83% |
Book Value vs Market Value Analysis
This analysis compares Borregaard ASA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.34x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.30x to 0.34x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-12-31 | $13.35 | $17.40 | x |
| 2010-12-31 | $9.98 | $17.40 | x |
| 2011-12-31 | $11.09 | $17.40 | x |
| 2012-12-31 | $17.26 | $17.40 | x |
| 2013-12-31 | $18.47 | $17.40 | x |
| 2014-12-31 | $19.41 | $17.40 | x |
| 2015-12-31 | $20.56 | $17.40 | x |
| 2016-12-31 | $26.79 | $17.40 | x |
| 2017-12-31 | $28.89 | $17.40 | x |
| 2018-12-31 | $31.23 | $17.40 | x |
| 2019-12-31 | $33.18 | $17.40 | x |
| 2020-12-31 | $36.79 | $17.40 | x |
| 2021-12-31 | $42.35 | $17.40 | x |
| 2022-12-31 | $43.96 | $17.40 | x |
| 2023-12-31 | $48.59 | $17.40 | x |
| 2024-12-31 | $50.50 | $17.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Borregaard ASA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 16.33%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.80%
- • Asset Turnover: 0.79x
- • Equity Multiplier: 1.90x
- Recent ROE (16.33%) is below the historical average (17.37%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 10.41% | 4.11% | 0.98x | 2.57x | $5.50 Million |
| 2010 | 18.04% | 5.20% | 0.97x | 3.57x | $80.20 Million |
| 2011 | 28.58% | 8.23% | 1.04x | 3.34x | $206.10 Million |
| 2012 | 15.82% | 6.93% | 1.11x | 2.05x | $100.40 Million |
| 2013 | 18.14% | 8.38% | 1.16x | 1.86x | $150.30 Million |
| 2014 | 17.21% | 8.48% | 1.05x | 1.93x | $139.90 Million |
| 2015 | 18.77% | 9.27% | 1.00x | 2.03x | $180.40 Million |
| 2016 | 20.72% | 12.36% | 0.96x | 1.74x | $287.10 Million |
| 2017 | 19.59% | 12.26% | 0.87x | 1.85x | $277.10 Million |
| 2018 | 15.24% | 9.95% | 0.80x | 1.91x | $163.70 Million |
| 2019 | 12.61% | 8.24% | 0.75x | 2.04x | $86.40 Million |
| 2020 | 11.89% | 8.18% | 0.76x | 1.91x | $69.20 Million |
| 2021 | 16.39% | 11.92% | 0.81x | 1.70x | $269.80 Million |
| 2022 | 20.30% | 12.96% | 0.85x | 1.85x | $452.60 Million |
| 2023 | 17.92% | 12.20% | 0.78x | 1.88x | $384.50 Million |
| 2024 | 16.33% | 10.80% | 0.79x | 1.90x | $318.90 Million |
Industry Comparison
This section compares Borregaard ASA's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $7,181,833,981
- Average return on equity (ROE) among peers: 7.11%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Borregaard ASA (BRRDF) | $594.77 Million | 10.41% | 0.67x | $1.39 Billion |
| AirBoss of America Corp (ABSSF) | $197.00 Million | -16.19% | 1.24x | $57.06 Million |
| Asia Carbon Industries Inc (ACRB) | $19.13 Million | 17.11% | 0.33x | $0.98 |
| Aimia Inc (AIMFF) | $1.29 Billion | -4.63% | 2.83x | $103.68 Million |
| L'Air Liquide S.A (AIQUF) | $11.83 Billion | 14.08% | 1.26x | $107.70 Billion |
| Akzo Nobel N.V (AKZOF) | $7.58 Billion | 14.03% | 1.29x | $9.73 Billion |
| Albemarle Corp (ALB) | $545.00 Million | 9.41% | 1.09x | $19.53 Billion |
| ALPEK S.A.B. de C.V (ALPKF) | $49.59 Billion | 15.64% | 1.50x | $214.40 Million |
| Altech Batteries Limited (ALTHF) | $97.54 Million | -5.87% | 0.01x | $27.89 Million |
| Arcadium Lithium plc (ALTM) | $333.00 Million | 14.14% | 0.12x | $6.26 Billion |
| Alto Ingredients Inc (ALTO) | $345.21 Million | 13.35% | 0.40x | $212.84 Million |